Aim

Welcome to the Drug Delivery Lab!
Administration of free drug to treat diseases, in many cases, is associated with critical drawbacks like off-target effects and low in vivo stability. This hinders the treatment of the disease. With our versatile expertise, we aim to reduce these shortcomings. Our lab focuses on using wide range of tools and concepts such as nano- and micro-particles, hydrogels, scaffolds and 3D organoids to generate treatment for diseases like Tuberculosis and Osteoarthritis. With our translational outlook, we plan to create clinically viable therapeutic options to treat such diseases.

Latest News

    • 7th Sep 2020
      Avijit Goswami and Priyanka Naik joins the laboratory as research associate and project associate respectively. Welcome!
    • 31st July 2020
      Rachit receives Wellcome-Trust/DBT India Alliance Intermediate Fellowship for the period January 2021- December 2025. Congratulations!
    • 19th June 2020
      First manuscript from the lab is now accepted in Biomaterials Science! Read more here.

Latest Publications

  • Kalapala Y.C.; Sharma P.R.; Agarwal R., Antimycobacterial potential of Mycobacteriophage under pathophysiological conditions. BioRxiv. doi: 10.1101/2020.05.16.100123.
  • Dhanabalan K.M.; Gupta V.K.; Agarwal, R., Rapamycin-PLGA microspheres induce autophagy and prevent senescence in chondrocytes and exhibit prolonged retention in mice joints. Biomaterials Science. 8 (2020) 4308 – 4321